Athena Athena

X
[{"orgOrder":0,"company":"Beyond Celiac","sponsor":"Provention Bio","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Beyond Celiac Partners with Provention Bio on Phase 2 Clinical Trial for Promising Celiac Disease Therapeutic","therapeuticArea":"Immunology","highestDevelopmentStatus":"Phase II","country":"U.S.A","productType":"Large molecule","productStatus":"New Molecular Entity","date":"September 2020","url1":"","url2":"","graph1":"Immunology","graph2":"Phase II"}]

Find Clinical Drug Pipeline Developments & Deals by Beyond Celiac

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Beyond Celiac has partnered with Provention Bio to provide clinical trial recruitment for the biopharmaceutical company’s Phase 2b PROACTIVE study of PRV-015.

            Lead Product(s): PRV-015

            Therapeutic Area: Immunology Product Name: PRV-015

            Highest Development Status: Phase II Product Type: Large molecule

            Partner/Sponsor/Collaborator: Provention Bio

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Partnership September 22, 2020

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY